GlassScriptPhysician profile
Rishi Singhal
NPI 1427412550
$1,339.51
in general payments reported to CMS, 2019-2025
14 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.50 · 2022: $19.46 · 2023: $281 · 2024: $514 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,201 · Entertainment: $66.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,200.88 |
| Entertainment | $66.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $418.11 | 2024-2025 | Iheezo, Vevye |
| Alcon Vision LLC | $174.32 | 2019-2025 | Rhopressa, Rocklatan |
| Bausch & Lomb Americas INC. | $114.14 | 2023-2024 | Xipere, Visudyne, Retisert |
| Abbvie INC. | $100.34 | 2023-2025 | Vuity, Lumigan, Alphagan P |
| Apellis Pharmaceuticals, INC. | $87.55 | 2025 | Syfovre |
| Mallinckrodt Hospital Products INC. | $87.41 | 2022-2023 | Acthar |
| Genentech USA, INC. | $87.08 | 2023-2025 | Vabysmo |
| Alimera Sciences, INC. | $77.74 | 2023-2024 | Iluvien, Yutiq |
| Optos, INC. | $66.67 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Ani Pharmaceuticals, INC. | $36.08 | 2025 | Iluvien |
| Astellas Pharma US INC | $26.93 | 2025 | Izervay |
| Coherus Oncology, INC. | $26.87 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $22.37 | 2023 | Eylea |
| Amgen INC. | $13.90 | 2024 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rishi Singhal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.